Simcere Pharmaceutical Group Limited
HKEX:2096.HK
6.23 (HKD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2012 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 2,007.162 | 1,657.6 | 973.139 | 3,270.241 | 354.804 | 1,187.647 | 572.584 | 178.162 |
| Short Term Investments
| 11.137 | 964.226 | 1,210.078 | 3.634 | 546.996 | 263.348 | 509.141 | 0 |
| Cash and Short Term Investments
| 2,018.299 | 2,621.826 | 2,183.217 | 3,273.875 | 901.8 | 1,450.995 | 1,081.725 | 178.162 |
| Net Receivables
| 2,644.645 | 2,337.443 | 2,398.767 | 1,871.012 | 1,336.916 | 951.31 | 697.975 | 1,093.433 |
| Inventory
| 614.562 | 302.373 | 235.157 | 262.673 | 248.174 | 233.869 | 187.241 | 120.932 |
| Other Current Assets
| 361.438 | 125.353 | 106.601 | 1,014.453 | 361.594 | 999.968 | 788.911 | 350.87 |
| Total Current Assets
| 5,638.944 | 5,453.784 | 4,979.549 | 6,466.832 | 2,897.641 | 3,665.628 | 2,784.021 | 1,743.397 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 2,191.614 | 2,171.91 | 1,961.644 | 2,191.413 | 1,934.479 | 1,397.115 | 1,186.715 | 840.632 |
| Goodwill
| 142.474 | 172.788 | 172.788 | 172.788 | 142.474 | 142.474 | 142.474 | 284.62 |
| Intangible Assets
| 715.786 | 379.896 | 59.691 | 77.108 | 33.768 | 49.345 | 65.907 | 362.934 |
| Goodwill and Intangible Assets
| 858.26 | 552.684 | 232.479 | 249.896 | 176.242 | 191.819 | 208.381 | 647.554 |
| Long Term Investments
| 1,579.842 | 2,555.864 | 1,441.289 | 1,771.542 | 676.463 | 1,035.146 | 986.094 | 56.785 |
| Tax Assets
| 317.002 | 326.713 | 289.972 | 210.093 | 274.698 | 174.483 | 194.663 | 0 |
| Other Non-Current Assets
| 268.005 | -279.842 | 1,256.21 | 53.634 | 807.347 | -125.856 | -164.856 | -1,544.971 |
| Total Non-Current Assets
| 5,214.723 | 5,327.329 | 5,181.594 | 4,476.578 | 3,869.229 | 2,672.707 | 2,410.997 | 1,544.971 |
| Total Assets
| 10,853.667 | 10,781.113 | 10,161.143 | 10,943.41 | 6,766.87 | 6,338.335 | 5,195.018 | 3,372.663 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 317.218 | 334.444 | 323.951 | 242.077 | 254.851 | 307.557 | 215.1 | 62.136 |
| Short Term Debt
| 1,094.981 | 1,350.823 | 1,561.643 | 1,831.038 | 1,670.184 | 2,196.851 | 1,014.39 | 0 |
| Tax Payables
| 170.569 | 144.421 | 92.822 | 60.95 | 145.624 | 173.3 | 69.697 | 0 |
| Deferred Revenue
| -79.848 | -1,697.189 | 0 | 0 | 0 | -2,723.345 | -1,479.444 | 0 |
| Other Current Liabilities
| 1,353.549 | 2,975.65 | 1,178.169 | 1,424.043 | 1,503.47 | 4,330.337 | 2,781.745 | 1,147.382 |
| Total Current Liabilities
| 2,685.9 | 2,963.728 | 3,063.763 | 3,497.158 | 3,428.505 | 4,111.4 | 2,531.791 | 1,209.518 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 334.243 | 155.921 | 74.239 | 1,468.98 | 1,270.772 | 121.009 | 303.217 | 2 |
| Deferred Revenue Non-Current
| 393.112 | 403.35 | 417.613 | 447.95 | 470.525 | 331.37 | 344.102 | 0 |
| Deferred Tax Liabilities Non-Current
| 102.676 | 115.291 | 142.771 | 193.598 | 116.604 | 208.422 | 232.755 | 0 |
| Other Non-Current Liabilities
| 115 | 0 | 0 | 0 | 0 | 1 | 2 | -2 |
| Total Non-Current Liabilities
| 945.031 | 674.562 | 634.623 | 2,110.528 | 1,857.901 | 661.801 | 882.074 | 2 |
| Total Liabilities
| 3,630.931 | 3,638.29 | 3,698.386 | 5,607.686 | 5,286.406 | 4,773.201 | 3,413.865 | 1,300.295 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 3,173.805 | 3,081.131 | 3,002.871 | 3,002.871 | 0.21 | 0.034 | 0.034 | 8.258 |
| Retained Earnings
| 3,837.325 | 3,061.248 | 2,601.969 | 2,147.437 | 1,465.722 | 1,249.537 | 1,517.65 | 1,254.464 |
| Accumulated Other Comprehensive Income/Loss
| 4,048.931 | 209.994 | 139.962 | 151.481 | 14.532 | 467.485 | 515.188 | 0 |
| Other Total Stockholders Equity
| -3,837.325 | 774.388 | 692.195 | 0 | 0 | -151.922 | -253.722 | 749.404 |
| Total Shareholders Equity
| 7,222.736 | 7,126.761 | 6,436.997 | 5,301.789 | 1,480.464 | 1,565.134 | 1,779.15 | 2,012.126 |
| Total Equity
| 7,222.736 | 7,142.823 | 6,462.757 | 5,335.724 | 1,480.464 | 1,565.134 | 1,781.153 | 2,072.368 |
| Total Liabilities & Shareholders Equity
| 10,853.667 | 10,781.113 | 10,161.143 | 10,943.41 | 6,766.87 | 6,338.335 | 5,195.018 | 0 |